NITI Aayog Panel to Drive AIIMS Modernization

NITI Aayog, the Indian government’s premier think tank, has established a committee to devise a roadmap for transforming AIIMS, New Delhi, into a world-class institution for medical research and healthcare excellence. Led by NITI Aayog member VK Paul, the committee will analyze current systems and propose reforms with specific timelines for their implementation. This initiative is part of a broader effort to enhance healthcare infrastructure, governance, and self-sufficiency in AIIMS.

Additionally, NITI Aayog has been working on Universal Health Coverage (UHC) and rare disease treatment affordability, partnering with CSEP Research Foundation to examine global UHC models. It has also facilitated the indigenous production of affordable drugs for rare diseases, significantly reducing treatment costs.

Key Highlights of AIIMS Transformation Panel

Committee Formation

  • Led by VK Paul, focusing on AIIMS New Delhi’s transformation.

Objectives

  • Assess current systems & propose reforms with clear timelines.
  • Improve patient inflow management and hospital governance.
  • Develop Key Performance Indicators (KPIs) for clinical, academic, and research excellence.
  • Enhance financial prudence & sustainability in AIIMS operations.

Focus Areas

  • Governance & transparency.
  • Research excellence.
  • Clinical & academic improvements.
  • Self-sufficiency & financial sustainability.

NITI Aayog’s Efforts on Universal Health Coverage (UHC)

  • Partnership with CSEP Research Foundation to study global UHC models.

Draft paper on healthcare financing strategies,

  • Addresses supply-side & demand-side financing.
  • Aims to improve healthcare accessibility, quality, and affordability.
  • Extensive government & stakeholder consultations planned to shape policies.

Rare Disease Drug Accessibility Initiative

  • Effort to provide affordable indigenous treatments for rare diseases.
  • 4 affordable drugs introduced, priced at 1/60th to 1/100th of imported versions.
  • 4 more drugs undergoing regulatory approval, expected to launch by year-end.
Summary/Static Details
Why in the news? NITI Aayog Panel to Drive AIIMS Modernization
AIIMS Transformation Panel Committee led by VK Paul to improve AIIMS systems, governance, and sustainability.
Key Focus Areas Patient inflow, KPIs, governance, financial sustainability, transparency.
Universal Health Coverage (UHC) Study NITI Aayog & CSEP Research Foundation examining global UHC models.
Healthcare Financing Reforms Addresses supply & demand-side financing to improve accessibility & affordability.
Affordable Rare Disease Drugs 4 drugs introduced at 1/60th to 1/100th of imported costs, 4 more in pipeline.
Shivam

Recent Posts

Weekly Current Affairs One Liners 08th to 14th December 2025

Weekly Current Affairs One-Liners Current Affairs 2025 plays a very important role in the competitive…

18 hours ago

Which Indian City is Known as the Footwear City?

India has many cities that are famous for their unique industries, and some of them…

1 day ago

Which Desert is known as the Cold Desert?

Some deserts are extremely hot, but some remain cold throughout the year. These cold deserts…

2 days ago

Top-10 News Media Companies in the World, Check the List

In today’s world, news media plays a very important role in sharing information quickly and…

2 days ago

PNB Housing Finance Appoints Ajai Kumar Shukla as New MD & CEO

PNB Housing Finance has announced the appointment of Ajai Kumar Shukla as its new Managing…

2 days ago

Department of Posts and BSE Sign MoU to Expand Mutual Fund Access Across India

In a major push towards deepening financial inclusion, the Department of Posts (DoP) and BSE,…

2 days ago